Clinical introduction of Monte Carlo treatment planning: A different prescription dose for non-small cell lung cancer according to tumor location and size

Radiotherapy and Oncology

Volumn 96, Issue 1, 2010, Pages 55-60

  van der Voort van Zyp, Noëlle C ^a   Hoogeman, Mischa S ^a   van de Water, Steven ^a   Levendag, Peter C ^a   van der Holt, Bronno ^a   Heijmen, Ben J M ^a   Nuyttens, Joost J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Dose prescription; Lung cancer; Monte Carlo; Stereotactic radiotherapy

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CYBERKNIFE; DOSIMETRY; LUNG NON SMALL CELL CANCER; MONTE CARLO METHOD; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MONTE CARLO METHOD; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 77953960654     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.04.009     Document Type: Article

References (25)

1. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
2. van der Voort van Zyp N.C., Prevost J.B., Hoogeman M.S., et al. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome. Radiother Oncol 91 (2009) 296-300
3. Lax I., Panettieri V., Wennberg B., et al. Dose distributions in SBRT of lung tumors: comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motions. Acta Oncol 45 (2006) 978-988
4. Rassiah-Szegedi P., Salter B.J., Fuller C.D., Blough M., Papanikolaou N., and Fuss M. Monte Carlo characterization of target doses in stereotactic body radiation therapy (SBRT). Acta Oncol 45 (2006) 989-994
5. Schuring D., and Hurkmans C.W. Developing, evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose. Radiat Oncol 3 (2008) 21
6. Aarup L.R., Nahum A.E., Zacharatou C., et al. The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: implications for tumour coverage. Radiother Oncol 91 (2009) 405-414
7. Available from: http://www.aapm.org/pubs/reports/rpt_85.pdf. Tissue inhomogeneity corrections for megavoltage photon beams. AAPM 2004.
8. Ding G.X., Duggan D.M., Lu B., et al. Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy. Med Phys 34 (2007) 2985-2994
9. Vanderstraeten B., Reynaert N., Paelinck L., et al. Accuracy of patient dose calculation for lung IMRT: a comparison of Monte Carlo, convolution/superposition, and pencil beam computations. Med Phys 33 (2006) 3149-3158
10. Knoos T., Wieslander E., Cozzi L., et al. Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations. Phys Med Biol 51 (2006) 5785-5807
11. Nuyttens J.J., Prevost J.B., Praag J., et al. Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: marker placement and early results. Acta Oncol 45 (2006) 961-965
12. Timmerman RD. A phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the treatment of patients with medically inoperable stage I/II non-small cell lung cancer. RTOG 0236.
13. van der Voort van Zyp NC, van der Holt B, van Klaveren RJ, Pattynama P, Maat A, Nuyttens JJ. Stereotactic body radiotherapy using real-time tumor tracking in octogenarians with non-small cell lung cancer. Lung Cancer.
14. Poll J.J., Hoogeman M.S., Prevost J.B., Nuyttens J.J., Levendag P.C., and Heijmen B.J. Reducing monitor units for robotic radiosurgery by optimized use of multiple collimators. Med Phys 35 (2008) 2294-2299
15. Hol M., Marijnissen J.P.A., van der Baan P., et al. Accuracy of the Monte Carlo dose calculation algorithm for Cyberknife treatment of small lung lesions [abstract]. Med Phys 35 (2008) 2953
16. Deng J., Jiang S.B., Kapur A., Li J., Pawlicki T., and Ma C.M. Photon beam characterization and modelling for Monte Carlo treatment planning. Phys Med Biol 45 (2000) 411-427
17. Deng J., Jiang S.B., Pawlicki T., Li J., and Ma C.M. Derivation of electron and photon energy spectra from electron beam central axis depth dose curves. Phys Med Biol 46 (2001) 1429-1449
18. Jiang S.B., Kapur A., and Ma C.M. Electron beam modeling and commissioning for Monte Carlo treatment planning. Med Phys 27 (2000) 180-191
19. Ma C.-M., Li J.S., Deng J., and Fan J. Implementation of Monte Carlo dose calculation for CyberKnife treatment planning. J Phys Conf Ser 102 (2008) 012016
20. Chetty I.J., Curran B., Cygler J.E., et al. Report of the AAPM Task Group No. 105: issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning. Med Phys 34 (2007) 4818-4853
21. Goldstraw P., Crowley J., Chansky K., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2 (2007) 706-714
22. Hurkmans C.W., Cuijpers J.P., Lagerwaard F.J., et al. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol 4 (2009) 1
23. Xiao Y., Papiez L., Paulus R., et al. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 73 (2009) 1235-1242
24. Baumann P., Nyman J., Lax I., et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 45 (2006) 787-795
25. Koto M., Takai Y., Ogawa Y., et al. A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 85 (2007) 429-434